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Hevosten mahahaavat ovat yleinen sairaus. Maha-suolikanavan  mukoosa on vahingoittunut ja haavauma voi yltää lamina 
propriaan asti. Sairauden diagnosointi tapahtuu tyypillisesti kliinisten oireiden ja hoitovasteen perusteella. Ainoa varma 
diagnosointimenetelmä on mahan tähystys. Tähystys on kallista ja vaatii erityistaitoa, jonka vuoksi olisi tarve löytää vaihtoehtoinen 
diagnosointimenetelmä. 
 
Terve suoliston mukoosa ei läpäise sakkaroosia ja se hydrolysoidaan ohutsuolessa monosakkarideiksi, joka imeytyy ohutsuolen 
mukoosan läpi. Jos hevosella on mahahaava, mukoosa on vahingoittunut ja sakkaroosi pääsee imeytymään sen läpi. Imeytynyt 
sakkaroosi voidaan todeta veressä. Tämän perusteella seerumin sakkaroosi pitoisuuden mittaaminen voisi olla hyvä vaihtoehto 
mahahaavan diagnosointiin. Sakkaroosin pitoisuus mahdollisesti myös korreloi mahahaavan vakavuuden kanssa. Tämän 
hypoteesin selvittämiseksi on suunnitteilla tutkimus, jossa suuri määrä hevosia tähystetään, jonka jälkeen niille annostellaan 
sakkaroosia ja otetaan verinäyte. Verikokeista määritellään sakkaroosin määrä ja verrataan tulosta mahahaavan vakavuuteen. 
 
Tähystystä varten hevoset on rauhoitettava. Yleisimmin hevosen rauhoituksessa käytetään detomidiniä ja butorphanolia. Useiden 
tutkimusten mukaan nämä aineet vaikuttavat mahalaukun tyhjentymiseen hidastavasti.  Jos mahalaukun tyhjentyminen hidastuu, 
sakkaroosi pysyy mahdollisesti pidempään mahalaukussa, mikä voi vaikuttaa sakkaroosin pitoisuuteen seerumissa. Sakkaroosin 
pitoisuuteen seerumissa voisi siis vaikuttaa se, onko hevonen rauhoitettu vai ei. Tämän tutkimuksen tavoite onkin selvittää 
rauhoituksen vaikutusta sakkaroosin imeytymiseen .  
 
Materiaalimme koostui kymmenestä terveestä hevosesta. Kaikille hevosille suoritettiin kliininen tutkimus ja niiltä otettiin verinäytteet 
maha-suolikanavan sairauden poissulkemiseksi. Ensimmäisessä kokeessa hevosille annosteltiin 16 tunnin paaston jälkeen 500 
grammaa sakkaroosia 10 % -liuoksena nenämahaletkulla suoraan mahaan ja verinäytteet otettiin 0,45, 90, 135, 180 ja 225 
minuuttia annostelun jälkeen. Seuraavassa kokeessa hevoset rauhoitettiin 16 tunnin paaston jälkeen ja niille suoritettiin 
mahalaukun tähystys. Tämän jälkeen niille annosteltiin sakkaroosi ja otettiin verikokeet ensimmäisen kokeen mukaisesti. 
Sakkaroosin pitoisuus veressä määritettiin GC-FID metodilla. Sakkaroosin pitoisuudesta tietyillä ajanhetkillä hevosen ollessa 
rauhoitettuna ja ei-rauhoitettuna muodostettiin kuvaajat. 
 
Sakkaroosi voitiin havaita seerumissa 45 minuutin kuluttua annostelusta ja sitä oli vielä havaittavissa 225 minuutin kohdalla. Ei-
rauhoitetuilla hevosilla sakkaroosin seerumipitoisuudet olivat suuremmat kaikkina mittaus ajankohtina. Kuvaajan malli oli sama 
kummallakin ryhmällä. Ei-rauhoitetuilla hevosilla huippu tuli jo 45 minuutissa, kun se rauhoitetuilla hevosilla tuli 90 minuutissa.  
 
Rauhoitetuilla hevosilla sakkaroosin imeytyminen oli hitaampaa. Tähän selityksenä voi olla tähystys ja siihen liittyvä mahalaukun 
täyttäminen ilmalla, joka suoritettiin ainoastaan rauhoitetuilla hevosilla.  Kuvaajien muotojen yhteneväisyyden perusteella 
sakkaroosin seerumipitoisuutta voidaan verrata rauhoitetuilla ja ei-rauhoitetuilla hevosilla, mutta viiterajojen pitää olla kummallakin 
ryhmällä erilaiset.  
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PREFACE 
 
 
This presentation includes three sections: a literature review, a research project and 
appendixes. Appendix I is a health assessment sheet which was used in the clinical 
examination. Appendix II is the results of the clinical examinations. In appendix III 
there are the results of serum biochemistries and complete blood counts. 
 
 
1 INTRODUCTION 
 
Gastric ulceration is a common disease in horses. The gastrointestinal mucosa is 
damaged and the ulcer can extend to the level of the lamina propria. (The Equine gastric 
ulcer council 1999.)  Gastric ulcers cause a variety of clinical signs including weight 
loss, poor body condition, lack of appetite, loose faeces and mild or recurrent colic. The 
disease is typically diagnosed by clinical signs and response to therapy.  Gastroscopy is 
at the moment the only method for definitive diagnosis. (Bell et al. 2007.) Gastroscopy 
is expensive and needs special equipment, and therefore an alternative method of 
diagnosis which is less invasive, inexpensive and practical would be very beneficial to 
the equine industry. Healthy gastrointestinal mucosa is not permeable to sucrose and 
normally it is hydrolysed in the small intestine into monosaccharides which are then 
absorbed through the small intestine. When a horse has gastric ulcers, sucrose 
permeates through the damaged mucosa and can be detected in the blood. Based on this 
premise, sucrose serum concentration could be a useful alternative method to identify 
animals with gastric ulcers and to monitor the effect of therapy. Furthermore, the 
concentration of sucrose in serum may be correlated to ulcer severity.  In order to 
investigate this hypothesis, a study is planned in which a large group of horses with and 
without naturally occurring gastric ulcers will undergo gastroscopy, followed by 
administration of sucrose and collection of sequential blood samples. Sucrose 
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concentration in blood will then be correlated to severity of gastric ulceration in order to 
determine if sucrose concentration in serum is a reliable marker of gastric ulceration. 
To perform gastroscopy, the horses will need to be sedated. Detomidine and 
butorphanol is a common combination to sedate a horse. Detomidine is an alpha-2 
adrenergic agonist and it produces changes in cardiovascular function (Tranquilli et al 
2007). According to several studies it also has an effect on gastric emptying. After 
administration of detomidine, gastric motility was decreased. Similar effects have been 
found with other sedatives. (Vainionpää et al 2013, Elfenbein et al 2009, Merritt et al 
1998, Sutton et al 2006.) Butorphanol is a synthetic agonist-antagonist opioid.  
Butorphanol has also been reported to have a delaying effect on gastrointestinal motility 
(Knych et al 2012, Sellon et al 2001.) If gastrointestinal motility is reduced, sucrose 
may stay longer in the stomach because of delayed gastric emptying, and that may have 
an effect on sucrose serum concentration when performing the sucrose permeability test 
on sedated horses. Conclusions drawn from the study about the reliability of the sucrose 
test to diagnose ulcers may not be comparable with a similar study performed on non-
sedated horses. Therefore, it is the objective of this study to investigate the effect of 
sedation on sucrose permeability in the stomach.  
 
 
2 LITERATURE REVIEW 
 
2.1 Equine gastrointestinal anatomy and physiology 
 
The gastrointestinal tract starts from the oral cavity and ends at the rectum.  It is 
composed of five layers: mucosa, submucosa, circular muscle fibres, longitudinal 
muscle fibres and serosa. Sympathetic and parasympathetic branches relay neural 
signals from the central nervous system and influence gastrointestinal function. 
Peristalsis, secretion and blood flow are usually regulated locally. (Wong et al. 2011.) 
The enteric nervous system is independent of the central nervous system. It consists of 
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neurons in the gastrointestinal tract that control microcirculation, motility, exocrine and 
endocrine secretions. (Koenig & Cote 2006.) 
Interstitial cells of Cajal (ICC) are pacemakers and mediators of certain forms of 
neurotransmission in the equine gastrointestinal tract. ICC take part in generating and 
maintaining normal gastrointestinal motility patterns. One of the most important 
properties is the generation of slow waves. Slow waves are continuous rhythmic 
pacemaker currents which take part in rate-limiting the peristaltic activity. ICC share 
common development origin with smooth muscle cells and are connected to them 
through low resistance electrical junctions. When current is generated in ICC, 
depolarization causes the activation of voltage-dependent Ca
2+ 
channels in smooth 
muscle cells. Current is transmitted to smooth muscle cells and the potential of 
gastrointestinal contractions is set. Neural inputs can affect the smooth muscle cell 
response to slow waves. Excitatory neurotransmitters activate non-selective cation 
channels and cause the increase in effectiveness of slow waves to bring the smooth 
muscle membrane potential to threshold. Inhibitory neurotransmitters cause the opposite 
effect by activating  K
 + 
-channels.  It has been proposed that ICC in the circular and 
longitudinal muscle layers of stomach would act as mechanoreceptors and be able to 
sense stretch of the muscle. (Fintl & Hudson 2010.) 
For our study, the most important part of the gastrointestinal tract is the stomach. 
Anatomically it can be divided into the cardiac oriﬁce, fundus, body, pyloric antrum and 
pylorus. It has a rich blood supply along the greater and lesser curvatures of the 
stomach. (Ellis 2011.) Stomach controls nutrient and drug delivery to the intestines. It 
grinds and mixes the content and releases it to the duodenum at a rate controlled 
duodeno-gastric reflexes. Gastric muscle contractions are two types: slow volume-
reducing contractions of fundus that drive gastric emptying and peristaltic contraction 
waves of antrus that grind and mix the content of stomach.  Basically fundus is a 
reservoir and supplier of chyme to the antrum where the antral contraction waves then 
break down and mix the chime. Pyloric sphincter controls the releasing rate of content 
to the duodenum. (Pal et al 2007.)   
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2.1.1 Measurement of gastrointestinal motility  
 
Horses have different disease syndromes that have been associated with gastric 
emptying disorders. To learn more about this association, measurement of 
gastrointestinal motility has become necessary. Gastrointestinal motility is determined 
as the net movement of intraluminal contents. There are three basic parameters to 
measure gastrointestinal motility: myoelectric activity, mechanical activity and transit 
of intraluminal contents. These parameters do not always accurately correlate with each 
other. (Koenig & Cote 2006.)  Nuclear scintigraphy is the most common method to 
measure gastrointestinal motility. In addition there are studies investigating orally 
administrated acetaminophen markers, lactose 13C-ureide breath test, the hydrogen 
breath test and wireless ambulatory capsules as possible measuring methods. 
 
2.1.1.1 Nuclear scintigraphy 
 
Nuclear scintigraphy is a common technique to evaluate gastric emptying.  It is easy to 
perform, accurate, sensitive and quantitative. The procedure is performed in a special 
nuclear scintigraphy room. Horses are fasted to empty the stomach and then 
administered a radioactive isotope via nasogastric tube followed by serial imaging of 
the stomach region . Radioactive isotopes emit radiation that is captured by external 
detectors, gamma cameras, to form two-dimensional
 
images. Images taken at different 
time points provide information about the location of the radioisotopes and 
consequently the rate of gastric emptying. (Lohmann et all 2000.) Although nuclear 
scintigraphy is very useful for measurement of gastrointestinal motility, it is not always 
possible to use. Nuclear scintigraphy is expensive and personnel need special training to 
work with it. Therefore alternative methods for the evaluation of gastric emptying have 
been studied.  
  
2.1.1.2 Acetaminophen marker 
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Acetaminophen, or paracetamol is a mild analgesic drug that is readily absorbed in the 
small intestine but not in the stomach.  Lohmann et al. (2000) demonstrated that 
absorption variables of orally administrated acetaminophen could be used as method to 
evaluate gastric emptying rate in horses. They found significant correlations with the 
values they gained from nuclear scintigraphy. This indicates that acetaminophen 
absorption may also be a valid method when evaluating gastric emptying rates in 
horses. Later on a similar of study was made by Lohmann et al (2002) in which gastric 
emptying was delayed using atropine sulfate, then determined with nuclear scintigraphy 
and absorption variables of orally administered acetaminophen. There was again 
significant correlation between the half-time of liquid-phase gastric emptying (T50) of 
both methods. In addition, Doherty et al (1998) had studied acetaminophen as a marker 
of gastric emptying and had published similar results.  
 
2.1.1.3 Lactose 13C-ureide breath test and the hydrogen breath test  
 
Undigested carbohydrate arrives in the caecum which starts the microbial H2 
production. H2 diffuses into mucosal capillary blood and produces a detectable increase 
in end expiratory breath H2 output. This is measured with the hydrogen breath test. 
Lactose 
13
C-ureide (
13
C-LU) is a glycosylureide compound, consisting of a sugar 
moiety (galactose-glucose) bound to a 
13
C-urea molecule. The glucose-urea bond is 
cleaved by colonic microflora. C-urea is then released and hydrolyzed. The lactose 
13
C-
ureide breath test measures the rate of appearance of exhaled 
13
CO2 after ingestion of 
the isotope. Sutton et al. (2011) compared the lactose 
13
C-ureide breath test (LUBT) 
with the hydrogen breath test (H2BT) for measuring the equine orocaecal transit time 
(OCTT). In the study they tested 8 horses with combined LUBT and H2BT. Sequential 
end expiratory breath samples were analyzed and OCTT calculated. They found that 
there were peaks in expiratory 
13
CO2 in all individuals after ingestion of the labeled test 
meal whereas H2 expiration was not consistent. Their conclusion was that the LUBT 
would be more reliable than the H2BT when measuring equine OCTT.  
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2.1.1.4 Wireless ambulatory capsules 
 
Wireless ambulatory capsules are ingestible capsules used on humans to measure 
pressure, pH and temperature as it travels through the gastrointestinal tract to assess 
gastrointestinal motility.  Stokes et al (2012) used wireless ambulatory capsules to 
determine gastric emptying time in ponies. WAC were administrated into the stomach. 
Data onluminal pH, temperature and pressure were collected by a receiver. Gastric 
emptying was presumed to have occurred when pH reached 8.  Some of the ponies also 
went through the standard nuclear scintigraphy test and the results were compared with 
WAC gastric emptying time. In this study WAC provided non-invasive physiological 
information, but the results were variable. Gastric emptying time as determined by 
nuclear scintigraphy did not correlate significantly with gastric emptying time 
determined by WAC.  The study showed that at the moment WAC is not a reliable tool 
for determination of gastric emptying in the horse.    
 
2.1.2 Factors affecting gastrointestinal motility 
 
While medicating the horse, we may also affect the gastrointestinal motility. 
Alternations on gastrointestinal motility may cause gastrointestinal disease e.g. 
ileus.Therefore the effect of medications on gastrointestinal motility has been widely 
studied in horses. Studies have mostly concentrated on the effects of sedation and 
analgesia.  
 
2.1.2.1 Sedatives 
 
The adverse effects of different sedatives on gastrointestinal motility of horses have 
been of interest to many researchers. Merritt et al (1998) studied the effects of xylazine, 
detomidine and a combination of xylazine and butorphanol on duodenal motility in 4 
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healthy horses. With all treatments, frequency of pressure peaks recorded from the 
gastric cannula were significantly reduced below their respective pretreatment values, 
but to variable degrees and durations. They found no significant difference between 
baseline values. Xylazine had the mildest effects that lasted 30 minutes after treatment. 
Detomidine had significant effects for 1 hour as well as the combination of xylazine and 
butorphanol. Merritt, Campbell-Thompson and Lowrey (1989) had earlier studied the 
effect of xylazine treatment on proximal gastrointestinal tract myoelectrical activity in 5 
healthy horses. They found that xylazine resets the duodenal migrating motility 
complex in the horse, but causes no major disruption to the proximal gastrointestinal 
tract motility. Elfenbein et al. (2009) studied the effects of detomidine on visceral and 
somatic nociception and duodenal motility. Among other influences (decrease in nose-
to-ground height, heart rate, skin temperature and respiratory rate), detomidine also 
significantly increased duodenal distension threshold and caused an immediate decrease 
in the amplitude of duodenal contractions for 50 minutes. Sutton et al. (2002) also found 
that detomidine has dose related inhibitory effects on gastric emptying. Detomidine 
prolonged both the gastric half-emptying time and duration of the lag phase. In the same 
study, xylazine also lengthened the duration of the lag phase, but the effect on the 
gastric half-emptying time was not significant. Doherty et al. (1999a) studied the effect 
of sedation on gastric emptying rate by monitoring serum concentrations of 
acetaminophen. In the study they used xylazine, butorphanol and acepromazine for 
sedation. After sedation the time to reach peak serum concentration increased 
significantly. Peak serum concentration decreased after xylazine was administrated and 
AUC decreased after acepromazine administration. The results indicate a delay in 
gastric emptying after sedation. In the study by Mitchell et al. (2005) the effect of 
xylazine was analyzed with ultrasonography. The main result was the effect of the 
feeding status before sedation with xylazine. Although gastrointestinal motility was 
decreased after administration of xylazine, horses that were fed had minimal changes in 
intestinal activity whereas changes with fasted horses were significant. Elfenbein et al 
(2011) studied the effect of ketamine as continuous rate infusion. Ketamine is a 
noncompetitive N-methyl-D-aspartate receptor antagonist often used as anesthetic. 
However, this study handled ketamine as an alternative analgetic. The result was that 
like other anesthetics, ketamine increased the gastrointestinal transit time and decreased 
fecal output.  
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2.1.2.2 Analgesics 
 
Drugs with analgesic impact have effects on gastrointestinal motility in different ways. 
Widely used non-steroidal anti-inflammatory drugs (NSAID´s), can cause damage to 
the gastrointestinal tract (Videla 2009). However, it seems that NSAIDs don´t have an 
impact on gastrointestinal motility. There were only a few studies about NSAID´s and 
gastrointestinal motility and in those studies the research was concentrated on the effect 
of NSAIDs in combination  with endotoxemia (Valk et al 1998b).  
Opioid agonists are used for moderate to severe pain in horses especially when there is a 
need to avoid the adverse effects of NSAID´s on the gastrointestinal tract. Opioids 
stimulate receptors in the gastrointestinal tract that cause alterations in motility, 
secretion, absorption, and blood flow (De Luca & Coupar 2006.) Boscan et al (2006a) 
investigated the result of this stimulation using morphine. They found that morphine 
increased intestinal transit time and decreased secretion of water into feces. They also 
studied (2006b) if this effect could be override with opioid antagonist N-
methylnaltrexone. The gastrointestinal effects of morphine were not significantly 
decreased by N-methylnaltrexone. Fugueiredo et al also (2012) studied the effects of 
morphine and got results indicating that morphine reduces gastrointestinal motility. 
Buprenorphine seem to have same kind of effects administrated intravenous or 
intramuscular route (Davis et al 2011).  
 
2.1.2.3 Other drugs 
 
Studies of the other drugs are mainly concentrated on treatment of gastrointestinal 
motility dysfunctions. Okamura et al. (2009) studied gastrointestinal prokinetic agents, 
mosapride, metoclopramide, cisapride and lidocaine that are used to treat decreased 
gastrointestinal motility. They found that mosapride, metoclopramide and cisapride all 
improved motility in the jejunum and mosapride also improved motility in the caecum.  
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Doherty et al (1999b), Valkt et al (1998a,b) and Meisler et al (2010) used serum 
concentrations of acetaminophen as a method to measure gastrointestinal motility when 
they studied the effect of drugs and endotoxin on gastric emptying. Doherty et al 
(1999b) divided horses in three groups: normal, fasted horses, horses given endotoxin 
intravenously and horses given metoclopramide and endotoxin intravenously. They 
compared serum acetaminophen concentration Tmax, Cmax and AUC among treatment 
groups. The study showed that endotoxin administration delayed gastric emptying and 
metoclopramide significantly ameliorated the effect. Valk et al studied the effect of 
cisapride (1998a) and phenylbutazone (1998b). In normal horses neither drug altered 
gastric emptying rates. However, when the drugs were separately combined with 
administration of endotoxin, cisapride  and phenylbutazone attenuated the delay on 
gastric emptying caused by endotoxin. Meisler et al (2010) divided horses into two 
groups: horses given endotoxin and horses given endotoxin plus yohimbine, an alpha2 
adrenergic receptor antagonist.  The results were the same as Doherty et al (1996b) got 
with metoclopramide and Valk et al (1998) with cisapride. Yohimbine seems to prevent 
the delaying effect of endotoxin on gastric emptying. Doherty et al (1998) used 
acetaminophen as a liquid marker and found in their study that atropine delayed gastric 
emptying and erythromycin had no effect. Yohimbine increased absorption of 
acetaminophen. Maher et al (2008) studied the effect of ranitidine on gastric emptying. 
Ranitidine is a histamine type 2 receptor antagonist and it is used in treatment of gastric 
ulcers to inhibit gastric acid secretion. Gastric emptying was measured using 
acetaminophen absorption model. According to the results, ranitidine didn´t have any 
significant effect on gastric emptying in vivo. Neostigmine methylsulfate was found to 
delay gastric emptying of particulate markers in the study made by Adams and 
MacHarg (1985). Horses were given plastic markers. Horses which were given 
neostigmine methylsulfate had more markers in the stomach and caudal third of the 
small intestine compared to the control group. 
 
2.1.2.4 Other  
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Only a few studies were found which investigated factors other than drugs affecting 
gastrointestinal motility. In a study made by Lammers et al (2005) gastric emptying was 
determined with serum acetaminophen concentration when horses had an indwelling 
nasogastric tube. No impact for indwelling nasogastric tube on gastric emptying was 
found in this study. However, Cruz et al (2006) studied the same subject and their 
results differed from the earlier study. According to their results, indwelling nasogastric 
tubes delayed gastric emptying. 
Lorenzo-Figueras et al (2005) studied how the high-fat versus high-carbohydrate diet 
effects on gastric relaxation and emptying. Gastric emptying was measured with the 
13
C-octanoic acid breath test and gastric tone by variations in volume of an intragastric 
bag. Gastric emptying rates didn´t differ significantly, though high-carbohydrate meals 
emptied initially more slowly. 
 
2.2 Effects of sedation  
 
In our study, horses were sedated in order to perform gastroscopy. Sedation on standing 
horses is also commonly preferred to general anesthesia when performing diagnostic 
and minor surgical procedures. General anesthesia is associated with a greater risk of 
mortality and morbidity in horses. General anesthesia is also expensive and requires 
expertise and appropriate facilities. (Johnston et al 2004.) Acepromazine and the alpha2 
adrenoceptor agonists are commonly used for sedation in horses. The sedative effect of 
these individual agents can be accelerated with the simultaneous use of opioids. (Taylor 
et al 2013.) Usually a single bolus of an alpha2 agonist will last long enough to finish a 
short procedure. With longer procedures, a continuous rate infusion could be a better 
choice than repeated injections. (Haininsch 2001.) Sedatives are used to cause a relaxed 
state. Williams et al (2012) studied with EEG if the state is sleep-like. Six horses were 
administrated acepromazine, butorphanol, xylazine and detomidine, each drug at 
separate time points and the results were recorded on an EEG. The effects varied 
between different sedatives, but qualitatively EEG findings on sedated horses matched 
with findings during natural sleep. Xylazine and detomidine triggered sleep, but it was 
limited to slow wave sleep.  Xylazine and detomidine also produced heart block and 
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startle responses similar to sleep.  Acepromazine didn´t promote a relaxed state in each 
case. 
 
2.2.1 Detomidine 
 
To sedate horses in the study, we used the combination of detomidine and butorphanol 
intravenously. Detomidine is an alpha-2 adrenergic agonist. It is commonly used to 
provide sedation, analgesia and muscle relaxation in horses. Alpha-2 agonists bind to 
and stimulate alpha-2 adrenergic receptors in the central nervous system and periphery. 
The effect of detomidine is stronger and lasts longer than sedation and analgesia 
produced by xylazine. Detomidine allows evaluation and treatment of horses that would 
otherwise be hard to handle. (Daunt, Steffey 2002.)  
Detomidine is administrated via intravenous, intramuscular or sublingual route. When 
administrated intravenously, sedation effect is quicker and with higher magnitude as 
well as other physiological and behavioral changes. (Mama et al. 2009.) In a study by 
l’Ami et al (2013) detomidine was given sublingually. According to their results, 
maximal ataxia was at 60 minutes and maximal sedation at 100 minutes. Also Gardner 
et al (2010) studied if detomidine could be used sublingually to cause an appropriate 
state to undergo veterinary and husbandry procedures under field conditions. 
Differences between detomidine and placebo was significant and the results promote the 
sublingual use of detomidine as one option. All parameters returned to baseline in 24 
hours. Detomidine can also be administrated epidurally at the first intercoccygeal space. 
The drug is lipophilic and gets into the systemic circulation rapidly. Epidurally 
administrated detomidine provides a longer lasting sedation suitable for surgeries such 
as standing laparoscopic ovariectomy and cryptorchidectomy. (Virgin et al 2010.) 
Detomidine is used alone and also in combination with butorphanol or other opiods to 
produce a more reliable sedation. Taylor et al (2013) studied if sedation requires both 
detomidine and buprenorphine. One group of horses was given detomidine and glucose 
intavenously, the other group detomidine and buprenorphine. According to the study, 
buprenorphine enhanced the sedation and the procedure was more likely to be 
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completed. There was no serious adverse effect marked; only ataxia was more severe 
and long-lasting with buprenorphine. Respiratory and cardiovascular effects were 
insignificant. Usually detomidine is given IV at doses ranging from 5 to 20 µg/kg or IM 
at doses ranging from 10 to 40 µg/kg. (Tranquilli et al 2007.) 
Detomidine produces changes in cardiovascular function. Changes are dose-dependent. 
In conscious horses, cardiac output decreases by 40 % to 45 % and heart rate decreases 
by 30 % to 35 % after IV administration at doses of 10 to 20 microgram/kg. Detomidine 
administration effects very little on pulmonary function, but has greater effects on 
esophageal transit time and gastrointestinal motility. (Tranquilli et al 2007.) 
Detomidine´s  side effects have been proved in several studies. According to study by 
Vainionpää et al (2013) and Elfenbein et al (2009), detomidine reduces heart rate 
significantly, causes heart blocks, reduces the gut sounds and prolongs defecation time 
after sedation. Yamashita et al (2000) compared cardiovascular effects of 
medetomidine, detomidine and xylazine. The effect on heart rate was insignificant with 
all drugs. Atrio-ventricular block was present with all drugs and it was most long-acting 
after administration of detomidine. All treatments produced hypertension as well as a 
decrease in cardio index and stroke volume. Medetomidine and detomidine decreased 
respiratory rate. All the effects were prolonged after administration of detomidine. 
Hyperglycemia has also been reported as one of the adverse effects (DiMaio Knych et 
al 2012). It has been studied, if the side effects could be eased when detomidine was 
combined with other drugs. Vaininopää et al (2013) used detomidine together with MK-
467, a peripherally acting alpha-2-adrenoceptor antagonist that selectively targets alpha-
2-adrenoceptors outside of the blood-brain barrier. According to their study, effects on 
intestinal motility and heart rate were significantly reduced when detomidine was used 
simultaneously with MK-467. DiMaio Knych et al (2012) gave horses yohimbine, a 
monoamine oxidase inhibitor that acts as an antagonist of alpha-2 adrenoceptors, 15 
minutes after detomidine administration. Yohimbine reduced sedation, bradycardia, 
atrioventricular heart block and hyperglycemia caused by detomidine. 
 
2.2.2 Butorphanol 
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Butorphanol is a synthetic agonist-antagonist opioid. It is a competitive µ-receptor 
antagonist, but exerts its analgesic action by acting as agonist at ĸ receptors. 
Butorphanol is been used with wide variety of veterinary species. Duration of analgesic 
effects depends on species, type and intensity of pain, dosage and route of 
administration. It is typically administrated via intravenous, the intramuscular or 
subcutaneous route. Butorphanol has very little effect on cardiopulmonary function. It 
does not induce histamine release when administrated intravenously. Butorphanol is 
often used in combination with other sedatives and tranquilizers, mainly with an alpha2-
agonist or occasionally acepromazine. With horses it is administrated intravenously for 
standing procedures or prior to induction of general anesthesia. For visceral pain it has 
potent but short-lived analgesic effect. (Tranquilli et al 2007.) Sellon et al (2001) 
studied the effect of butorphanol when administrated by single intravenous injection or 
continuous intravenous infusion and continued with the topic later on comparing the 
pharmacokinetics of butorphanol after intramuscular and intravenous injection (2008).  
According their results, single intravenous injection caused adverse behavioral and 
gastrointestinal tract effects such as ataxia, decreased borborygmi, and decreased 
defecation that were minor or did not appear at all with continuous intravenous infusion. 
Although the adverse effects were minor with continuous intravenous infusion, the 
effect was prolonged and number of fecal piles passed during the 24-hour treatment 
period was significantly less in butorphanol treated horses when compared with 
controls. Intramuscular injection caused very little adverse affects, but to maintain target 
plasma butorphanol concentrations, injections every 3h would be necessary. Knych et al 
(2012) administrated butorphanol intravenously and reported adverse effects including 
decreased gastrointestinal motility and increase in heart rate. 
 
2.3.1 Diagnosis of gastric ulcers 
 
Gastric ulceration is typically diagnosed by nonspecific clinical signs and response to 
therapy (The Equine gastric ulcer council 1999). Clinical signs in adults are variable 
including weight loss, poor body condition, lack of appetite, mild or recurrent colic and 
loose faeces. Foals have more specific clinical signs such as poor body condition, less 
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time spent suckling, diarrhea, ptyalism, bruxism and intermittent colic. (Bell et al. 
2007.)   
For definitive antemortem diagnose of EGUS, gastroscopy is currently the only method. 
Horses are fasted for a minimum of 6 hours, pylorus visualized with 3-m endoscope and 
lesions scored according to severity. (Bell et al. 2007.) Two kinds of endoscopic 
equipments can be used: fibreoptic and video. To get a better view, the stomach is 
distended by insufflation with air. Additionally tap water is flushed through the biopsy 
channel to rinse gastric contents from the mucosa. (The Equine gastric ulcer council 
1999.) 
Because gastroscopy is not always possible, there are efforts to find alternatives for 
diagnostics of gastric ulcers. For instance, it has been reported that gastric ulcers could 
be evaluated by sucrose concentrations in urine after administration via nasogastric 
intubation. When gastric mucosa is healthy, sucrose is transported to the small intestine 
and hydrolyzed to glucose and fructose. Normally there are only trace amounts of 
sucrose in the urine. If the gastric mucosa is damaged, sucrose is able to penetrate the 
gastric wall and enter the circulation, filtered from the blood by the kidneys and finally 
concentrated and excreted in the urine. (O’Conner et al. 2004.) O ’Conner et al. (2004) 
studied the possibility to detect gastric ulcers in horses by evaluating urine sucrose 
concentrations. Horses were administered sucrose by nasogastric intubation and urine 
collected at 2 and 4 hours after intubation. Horses were also gastroscoped and gastric 
ulcers scored by severity with range 0 to 3. Horses were administrated omeprazole for 
21 days and finally sucrose testing and endoscopy were repeated.  They found in their 
study correlation with higher urine sucrose concentrations for horses with ulcer severity 
scores over 1. Urine sucrose concentrations and ulcer severity scores decreased after 
omeprazole treatment. They found the urine sucrose concentration to be a reliable but 
imperfect indicator of gastric squamous ulcers.  
A faecal occult bloody test was found to be a possible method when diagnosing EGUS 
(Pellegrini 2005). Horses were euthanized and necroscopy was performed. A sample of 
feces was collected and examined with a correlated guaiac-based fecal occult test 
(gFOBT). 90 % of the horses with EGUS got positive predict value from gFOBT. 
Negative predict value was 17%.  The study indicates that a horse with positive gFOBT 
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is likely to have gastric ulcer.  Recent rectal biopsy, rectal examination or other rectal 
trauma may give a false positive test result. 
Taharaguchi et al (2007) studied serum samples from foals. Objective was to find serum 
indicators of gastric ulcers. Gastric ulcers were detected endoscopically. They found 
serum α1-antirypsin, a plasma glycoprotein, in 44/47 foals with gastric ulcers and only 
3/22 in healthy foals. α1-antirypsin could be a protective response against proteolytic 
activities in damaged tissues, but more research is needed. 
Hewetson et al (2006) studied the possibility to use sucrose concentration in blood as an 
assessment to detect gastric ulcers on horses. They suggested that increased sucrose 
concentration in blood would indicate gastrointestinal tract damage, for healthy 
gastrointestinal tract is not permeable for sucrose. Blood collection would be easier that 
urine collection, which is with horses technically demanding to perform. In the study 
horses were fasted and then administrated sucrose by nasogastric intubation. Blood 
samples were collected at 0, 15, 30, 45, 60, and 90 minutes. Horses were gastroscoped 4 
hours later and gastric ulcers scored by severity with 4-point ulcer scoring system. They 
found that horses with moderate to severe gastric ulceration had a significant increase in 
serum sucrose concentration after administration of sucrose and after 45 minutes serum 
sucrose concentration was correlated with ulcer severity. Results of the study suggest 
that blood test may be a reliable screening test, though it would not replace gastroscopy. 
Blood test may help to identify animals with gastric ulcers and animals could then be 
gastroscoped. This would be cost saving for horse owners and help veterinarians that do 
not have access to gastroscopy.  To get more information about this diagnostic 
possibility, a similar study design is planned with larger group of horses with and 
without naturally occurring gastric ulcers to determine if sucrose concentration in serum 
is a reliable marker of gastric ulceration. Horses will be sedated for gastroscopy and it is 
not clear if sedation has an effecton gastrointestinal motility. If sedation does alter 
gastrointestinal permeability, it  may have an effect on sucrose serum concentrations 
when performing the sucrose permeability test on sedated horses. Therefore the 
objective of this study was to investigate the effect of sedation on the sucrose 
permeability curve.  
 
18 
 
 
3 MATERIALS AND METHODS 
 
3.1 Subjects 
 
Ten adult, clinically healthy horses were used in this study. The breeds comprised of 
eight Finnish horses and two warmbloods.  Nine horses were geldings and one horse 
was a mare. Horses age ranged from 10.0 to 19.1 years (mean 14.0). The body weight 
ranged from 485 to 616 kg (mean 542 kg).  The body condition was scored from 1 to 9, 
1 being poor and 9 being extremely obese (Henneke et al. 1983).  The mean body 
condition score was 6. A full clinical examination was performed on each horse. Horses 
were owned by the Equine college Ypäjä Finland and used for education of the students. 
The horses were housed separately in stalls. Free choice hay and water was provided for 
all horses, except for the fasting periods before both examinations (16 hours) and time 
before and during sucrose administration and blood collection. The protocol for this 
study was approved by the National Animal Experiment Board of Finland 
(Eläinkoelautakunta ELLA). 
 
3.1 Experimental design 
 
This study was a cross over study. 10 horses were sucrose tested without prior sedation 
and gastroscopy. After a washout period of 2 days, the same group of horses was 
sucrose tested again after sedation and gastroscopy, and the sucrose concentration in 
blood at each time point was compared. 
 
3.2 Sucrose administration and collection of blood samples 
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Horses were fasted for 16 hours prior to both examinations. To ensure this, horses were 
fitted with muzzles.  Fourteen gauge, 12,7 cm polyurethane catheters were placed in the 
left jugular vein of each horse and anchored with nylon stitches. Ten ml of blood was 
collected from the cannula and placed into vacuumed clot tubes.  After blood collection 
the cannula was flushed with 10ml of heparin. For the first part of the experiment, 
sucrose was given to horses immediately after blood sample zero was collected. Horses 
were dosed with 500g sucrose as 10 % solution via nasogastric tube. Blood samples 
were then collected 45, 90, 135, 180 and 225 minutes after sucrose administration. After 
each blood collection the cannula was flushed with 10ml of heparin
a
. When the last 
blood collection was over, the catheter was removed and horses were given hay.   
The second part of the experiment was performed two days later. After blood collection 
zero, horses were sedated with the combination of 0,3 ml detomidine hydrochloride
b 
and 
0,6ml butorphanol tartrate
c
 intravenously and gastroscoped.  To get the luminal surface 
of the stomach visible, the biopsy channel of the endoscope was used to distend the 
stomach by insufflation with air. Additionally tap water was flushed through the biopsy 
channel to rinse gastric contents from the mucosa. Gastroscopy was performed with a 3-
m equine videoendoscope
d 
and examinations were recorded. If found, gastric ulcers 
were located and scored using a published four-point gastric ulcer scoring system 
(Andrews et al 1999) (Table 1).  When gastroscopy was finished, air was sucked 
through the biopsy channel in order to get the stomach deflated. Horses were dosed with 
500g sucrose as a 10 % solution via nasogastric intubation immediately after 
gastroscopy had been performed. After that, blood samples were collected at 45, 90, 
135, 180 and 225 minutes after sucrose administration. When the exam was over, the 
catheters were removed and the horses were given hay.  
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Table 1. Four-point gastric ulcer scoring system 
Score Description             
0 
Mucosal epithelium is intact; there may be hyperemia (reddening) 
or    
  
hyperkeratosis (yellow appearance to the squamous 
mucosa)     
1 
Small single or multiple 
ulcers           
2 
Large single or multiple 
ulcers           
3 Extensive (often coalescing) ulcers with areas of apparent deep ulceration 
 
3.3 Sample processing and analyses 
 
Approximately 3 hours after the last collection, blood samples were centrifuged for 10 
minutes at 3660g and the serum was frozen and stored at -80 ⁰C .  Serum samples were 
analyzed using a gas chromatography-flame ionization detection (GC-FID method.  For 
GC-FID analysis samples were first thawed and mixed using a vortex and then two 
hundred µL of serum was added to an Eppendorf tube with 20 µL of internal standard 
(trehalose, 100 µg/ml). Zero point six mL acetonitrile-water (90:10) was added to the 
tubes and centrifuged for 10 min at 10 000 x g to precipitate proteins. The supernatant 
was set in a vacuum evaporator at 60 ⁰C to dry.  The residues were purged with nitrogen 
for 10 s and dissolved in 0.1 mL anhydrous pyridine and sonicated for 5 min. To 
convert sucrose and trehalose to their TMS derivative, 0,1 ml TMSI was added.  
Samples were capped tightly and heated at 100 ⁰C for 1 hour.  After reaction, the 
samples were centrifuged for 5 min at + 4 °C at 1711 x g and the aliquot of the mixture 
transferred to a autosampler vial. Analysis was done immediately.  
An agilent 7890A instrument equipped with a flame ionization detector (FID) and 
Agilent 7683B autosampler (Agilent, China) was used for gas chromatography (GC).  
Single tapered glass liner fitted to an injector into a 2.5 m x 0.32 mm ID retention gap 
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(uncoated precolumn) was used to inject aliquots (1 µL) of the mixture in pulsed 
splitless mode at a pressure of 80 psi for 0.4 min. The retention gap and a 30 m x 0.320 
mm I.D. fused-silica capillary column were attached, coated with 0.25 µm thickness 
HP-5 stationary phase (J&W Scientific, Folsom, CA, USA). Oven temperature was first 
held 95 ⁰C for 2 min then increased at the rate of  30 ⁰C/min till it was 205 ⁰C where it 
was held at for 3 min and eventually oven temperature was increased to 250 ⁰C at the 
rate of 1 ⁰C/min. The temperatures for detector and injector were 300 ⁰C and 230 ⁰C. 
The purge flow rate was 60 ml/min and after 0.5 min the purge valve was turned on. 
Carrier gas for the mobile phase was helium at a constant flow rate of 4.8 ml/min. 
Helium (30 ml/min) was also used as make-up gas for the flame ionization detector.  
Auxiliary gases were hydrogen (45 ml/min) and synthetic air (400 ml/min).  After every 
run, the column was backflushed at 300 °C for 10 void volumes.  
 
3.4 Statistical analysis 
 
The test hypothesis was that there is no difference between the two treatments (i.e. 
sedation and no sedation) at each time point.  A Wilcoxon signed-rank test for non-
parametric data was used to compare the cumulative amount of sucrose permeated at 
each time point with and without sedation. The p value and confidence intervals at each 
time point were then reported. Significance was set at P<0.05. The data was plotted on a 
line graph to create two sucrose permeability curves: with and without sedation. 
 
 
4 RESULTS 
 
4.1 Clinical examination, blood sample analysis and gastroscopy 
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A clinical examination was performed on all the horses. No abnormalities were found 
and the results for all the horses were normal. CBC and blood chemistry were mostly 
within reference range for all horses. Only a few clinically insignificant alterations 
occurred. Horse 003 had a slight increase in serum concentration of CK and AST (903 
and 692 U/I, respectively) when compared to the reference interval in the laboratory 
(<350 and <604 U/I, respectively). Horse 010 had a slight increase in serum fibrinogen 
(4.6 g/l) when compared to the reference range (<4.0 g/l). Gastroscopy revealed 
endoscopically visible gastric ulceration in 8/10 (80 %) horses. Scores for these ulcers 
varied from 0 to 2.  
 
4.2 Estimation of sucrose permeability 
 
When horses were administered a 10 % sucrose solution via nasogastric tube, no 
adverse effects occurred and the solution was well tolerated among all the horses, both 
with or without sedation. Sucrose was detected in serum at time point 45 minutes and 
was still detectable at 225 minutes post-sucrose administration in all horses, sedated or 
not.  
 
4.2.1 Non-sedated horses 
 
When horses were not sedated, sucrose serum concentrations peaked for all horses 
between 45 and 90 minutes (7 horses peaked at 45 minutes and 3 horses at 90 minutes) 
and then gradually decreased. In the beginning, at time point zero, sucrose concentration 
was 250 pg/ µl in all horses. Mean concentrations of sucrose in serum peaked at 45 
minutes and decreased gradually. Mean sucrose serum concentration was 2958,30 pg/µl 
when sucrose serum concentration peaked at 45 minutes and 1890 pg/ µl on last 
detection time point at 225 minutes. 
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4.2.2 Sedated horses 
 
When horses were sedated, sucrose serum concentrations peaked for all horses between 
45 and 180 minutes (4 horses peaked at 90 minutes, 3 horses at 135 minutes, 2 horses at 
45 minutes and 1 horse at 180 minutes). Serum sucrose concentration decreased 
gradually, except with two horses where the sucrose serum concentration started to rise 
again at 180 minutes (one horse had peaked at 45 minutes and the other at 90 minutes) 
and was still increasing at 225 minutes and with one horse, which had two peaks in 
serum concentration, at 45 and 135 minutes. Mean concentration peaked at 90 minutes 
and decreased gradually. Mean sucrose serum was 1958,60 pg/µl at peaking time point 
and 1474,40 pg/µl at 225 minutes. 
 
4.2.3 Group comparison 
 
The cumulative increase in sucrose for non-sedated horses was significant (p<0.05) at 
all time points. 
 
Table 2. Sucrose serum concentration [pg/µl] measured 0-225 minutes after 
administration of 10 % sucrose solution to clinically healthy, non-sedated horses.  
 
 
Horse No. 001 002 003 004 005 006 007 008 009 010 Mean SD
0 250,00 250,00 250,00 250,00 250,00 250,00 250,00 250,00 250,00 250,00 250,00 0,00
45 960,00 1313,00 4133,00 3247,00 2391,00 5987,00 1785,00 4142,00 4321,00 1304,00 2958,30 1667,66
90 800,00 800,00 1872,00 3743,00 2026,00 5073,00 1490,00 4149,00 5280,00 1114,00 2634,70 1756,63
135 800,00 800,00 2344,00 3539,00 1469,00 4523,00 1409,00 3695,00 4773,00 1184,00 2453,60 1546,84
180 800,00 800,00 1557,00 2538,00 1295,00 3264,00 1086,00 3393,00 4543,00 1070,00 2034,60 1314,7
225 800,00 800,00 1324,00 2865,00 1252,00 2878,00 964,00 2865,00 4290,00 862,00 1890,00 1231,77T
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Table 3. Sucrose serum concentration [pg/µl] measured 0-225 minutes after 
administration of 10 % sucrose solution to clinically healthy, sedated horses. 
 
 
Figure 1.  Sucrose serum concentrations in 10 clinically healthy horses with and 
without sedation after oral administration of 10 % sucrose solution. 
 
Horse No. 001 002 003 004 005 006 007 008 009 010 Mean SD
0 250,00 250,00 250,00 250,00 250,00 250,00 250,00 250,00 250,00 250,00 250,00 0,00
45 800,00 1013,00 2760,00 1631,00 1010,00 1132,00 800,00 2726,00 4656,00 1588,00 1811,60 1233,68
90 1120,00 1295,00 2941,00 2142,00 1384,00 1798,00 800,00 3888,00 2723,00 1495,00 1958,60 963,932
135 1262,00 1787,00 3177,00 1719,00 1293,00 1360,00 910,00 2760,00 3093,00 1415,00 1877,60 824,386
180 897,00 1186,00 1488,00 1298,00 1360,00 1204,00 936,00 2228,00 3058,00 1721,00 1537,60 660,01
225 800,00 956,00 1882,00 1313,00 1934,00 1077,00 837,00 1881,00 2190,00 1874,00 1474,40 530,017T
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Figure 2.  Sucrose serum concentrations in 10 clinically healthy horses with and 
without sedation after oral administration of 10 % sucrose solution. 
 
 
5 DISCUSSION 
 
5.1 Introduction 
 
The objective of this study was to determine how sedation affects the sucrose 
permeation curve in horses with and without prior sedation. The study included two 
parts, first blood samples were collected at various time points from non-sedated horses 
and in the second part of the study from sedated horses. During the second part of the 
study the horses were also gastroscoped. At time point zero, all horses were 
administered sucrose through a nasogastric tube. Blood samples were then analyzed for 
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sucrose serum concentration. Using the sucrose serum concentration curve, sucrose 
permeability could then be compared with sedated and non-sedated horses to determine 
if sedation and /or gastroscopy affected sucrose permeation. 
 
5.2 Clinical examination, blood results and gastroscopy 
 
Study horses were clinically examined and blood samples taken for CBC and serum 
biochemistry. Results were normal. This ruled out basic illnesses that would effect on 
sucrose permeability or gastrointestinal motility. Horses were also gastroscoped in order 
to demonstrate a situation from real life. The majority of the horses (80 %) had evidence 
of mild gastric ulcers. Even though gastric ulcers may effect on sucrose permeability, 
this did not influence the results because the same horses were used as a control group.  
 
5.3 Level of sedation 
 
This study was performed to investigate the effect of sedation on sucrose concentration 
in blood. Sedatives used in this study were detomidine and butorphanol. This 
combination is often used for sedation on horses. When an alpha-2 adrenergic agonist 
and an opioid are combined, sedation is more reliable (Tranquilli et al 2007.) 
Detomidine and butorphanol were administrated intravenously which provides a potent 
and longer sedation compared to intravenous or sublingual route (Mama et al 2009.) 
The manufacturer recommends 0,1-0,3 ml/100g detomidine combined with 0,4-0,5 
ml/100g butorphanol intravenously for sedation. The mean weight of the study horses 
was 542 kg. In the study we used 0,3 ml detomidine and 0,6 ml butorphanol to induce 
mild sedation. Horses needed to be able to walk from the stables to the examination 
room where gastroscopy was performed and back. The level of sedation was adequate 
to perform gastroscopy successfully. Study horses were used for education and were 
therefore used to being handled by strangers. In practice, some patients might need a 
stronger level of sedation. Sutton et al (2002) found in their study that the effect of 
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detomidine on gastric emptying time is dose dependent. In that case, different doses in 
the same horse could have an effect on gastric emptying and therefore on sucrose serum 
concentration. For this reason, if gastric ulcers were monitored by sucrose concentration 
in blood, it is recommended that the same dose of sedation is used each time. 
 
5.4  Effect of sedation on sucrose permeation 
 
 Our hypothesis was that sedation slows down gastric motility. Many studies have come 
to the same conclusion. Merritt et al (1998) investigated detomidine and found 
significant effects on duodenal motility for up to 1 hour. Elfenbein et al (2009) found 
similar results, except that the effect lasted for 50 minutes. In our study the last blood 
sample was collected at 225 minutes and there was still a difference in serum sucrose 
concentration between sedated and non-sedated horses. Movements of the stomach 
transport the content of stomach to the small intestine. In the small intestine sucrose is 
hydrolyzed into glucose and fructose. When gastric motility slows down, sucrose is 
transferred to the intestines after longer period of time than normally. In that case 
sucrose would have more time to permeate through the stomach mucosa. According to 
our hypothesis, serum concentration would be higher with sedated horses than with non-
sedated horses whose normal gastric motility would carry the sucrose faster to the 
intestines to be broken down. However, the results of our study show lower sucrose 
concentrations in blood for sedated horses.  Although the shape of the curve stayed the 
same with sedated and non-sedated horses, the sucrose permeability values with sedated 
horses were lower in its entirety. Also sucrose serum concentration peaked later with 
sedated horses. Mean peak time point was 45 minutes with non-sedated and 90 minutes 
with sedated horses. This indicates that when horse is sedated, sucrose permeability is 
decreased and occurs more slowly than when they are not sedated. These results are 
contrary to our hypothesis. 
One explanation could be the whole gastroscopy process that was only performed on 
sedated horses. The stomach was distended by insufflation of air in order to get the 
luminal surface of the stomach visible. After gastroscopy the stomach was deflated. It is 
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conceivable that the air insufflated is not completely deflated and the stomach stays 
more distended than normally. Sucrose lies in the bottom of the stomach and therefore 
only a limited area of gastric mucosa is exposed to sucrose. In contrast, horses that were 
not sedated and did not undergo gastroscopy would have very little air in the stomach, 
allowing for a extensive contact between the mucosa and the sucrose solution.  If 
sucrose does not contact with the whole gastric mucosa, less amount of sucrose is 
absorbed in the stomach and larger amount of sucrose is hydrolyzed in the small 
testiness and is not detected in the blood samples.  When a horse is not sedated, pleated 
stomach walls expose the gastric mucosa to the stomach content and more sucrose is 
absorbed before being transporting to the intestines. Sucrose serum concentration peaks 
earlier and therefore sucrose concentration in blood is higher.  
 
5.5 Peak serum concentration 
 
In our study sucrose serum peaked at different time points with some horses. This is not 
suprising as Lohmann et al (2000) demonstrated that there is variation in gastric 
emptying rates between individuals. In their study, they found that the rate of liquid 
phase emptying in normal horses varied from 27.9 to 87.3 minutes. However, variation 
between individuals was much wider with sedated horses. One explanation could be 
gastric ulcers. When gastric motility decreases, sucrose stays in the stomach for a longer 
period of time and the possibility to permeate into the blood via gastric ulcers increases. 
In the study by Hewetson et al (2006), horses with moderate to severe gastric ulcers had 
a clear increase in sucrose serum concentration. Horses with grade 3 gastric ulcers had a 
high peak of serum sucrose concentration at 45 minutes. In that study horses were not 
sedated. The effect of sedation on serum sucrose permeability with different grades of 
gastric ulcers might be interesting to study, but it would need a large number of horses. 
The other explanation for variation of peak points with sedated horses is that the effect 
of sedation is variable with individuals. The body weight ranged from 485 to 616 kg, 
but dose of the sedatives was the same. The concentration of the sedatives was different 
in horses. That could have effect on the gastric emptying time.   
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6 CONCLUSION 
 
Our hypothesis was that sedation would affect gastrointestinal motility and with the 
result that sucrose serum concentration would be higher when horses were sedated. Our 
study indicates that it is the opposite. Non-sedated horses had higher sucrose serum 
concentrations the sedated horses. Sucrose serum concentration also peaked later with 
sedated horses. Nevertheless, the sucrose permeability curve was the same with both 
groups. That indicates we can rely on our results when making conclusions about 
sucrose test reliability by extrapolating the results from sedated horses to horses that 
undergo sucrose testing without sedation. Because of the differences in sucrose 
concentrations, cut-off values for sedated and non-sedated horses need to be considered. 
For sedated horses they need to lower than for horses without sedation. Cut-off values 
are needed when assessing gastric permeability to diagnose gastric ulcers. Defining 
these cut-off values would need a big group of horses. There is a planned study to 
investigate if the concentration of sucrose in serum may be correlated to ulcer severity. 
At the same time it would define cut-off values for severity of gastric ulcers. The results 
of our study are clear and confirm that conclusions drawn from the study about the 
reliability of the sucrose test to diagnose ulcers with sedated horses is comparable with 
a similar study performed on non-sedated horses. 
 
 
7 FOOTNOTES  
 
a 
Heparin, LEO Pharma A/S, Ballerup, Denmark 
b 
Domosedan, Orion oyj, Espoo, Finland 
c
 Butordol, Intervet international B.V, Boxmeer, Netherlands 
d
 Olympus GIF-100, Olympus America Inc, Melville, NY, USA 
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      STUDY DATA SHEET 
            
  Date:    Identification number:   
            
  
Body Condition: Sex: Weight:                                     (kg) 
  
Breed: Age:   
  
General status: Locomotion: 
  
Behaviour: Coat: 
  
Management : Stable vs. Pasture ? Chenge: yes / no 
  
Feed What is fed and how much? How often Chenge: yes / no 
  
De-Worming Interval Last de-wormed What product was used: 
  
      
  
Drugs 
Name Amount Start date?  End date? 
          
          
          
  
Physical 
Examination 
Resp. Rate/min: CRT / sec: 
  
Pulse rate / min: MM colour: 
  
Temperature:   
  
Gastrointestinal 
function 
Teeth: Abdominal auscultation:  
  
Abdominal appearance: LU RU 
  
LL RL 
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  Gastronomy findings 
    
  Ulcer Score 
0 1 2 3 4 5 
  
  
Defecation 
Amount Consistency Last passed 
        
  Notes : 
  
                  
                  
  Time Study Activity blood samples Actual time and notes 
  T0 Place temporary catheter   
  T0 blood sample   
  T0 
Dose horses with 500g sucrose 
via nasogastric tube   
  T45 Blood sample   
  T90 Blood sample   
  T135 Blood sample   
  T180 Blood sample   
  T225 Blood sample   
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Clinical examination results Wb= Warm blood Fh= Finnhorse 
Horse No. 1 2 3 4 5 6 7 8 9 10 
Sex gelding gelding mare gelding gelding gelding gelding gelding gelding gelding 
Breed Wb Fh Wb Fh Fh Fh Fh Fh Fh Fh 
Weight (kg) 570 590 515 616 558 514 550 530 485 495 
Body condition  7/9  5/9  2/3  2/3  7/9  2/3  7/9  7/9  2/3  7/9 
Pulse rate/min 40 38 38 38 40 30 33 32 48 30 
CRT/sec < 2 < 2 < 2 < 2 < 2 < 2 < 2 < 2 < 2 < 2 
MM colour pink 
pale 
pink pink 
pale 
pink pink 
pale 
pink 
pale 
pink 
pale 
pink 
pale 
pink 
pale 
pink 
Temperature 
(C°) 36.6 37 37.3 37.4 37.5 37.6 37.6 37.5 37.4 37.6 
Abdominal  auscultation                   
LU + ++ ++ + + ++ ++ ++ ++ ++ 
LL +  ++ ++ + + ++ ++ ++ ++ ++ 
RU  + ++ ++ + + ++ ++ ++ ++ ++ 
RL + ++ ++ + + ++ ++ ++ ++ ++ 
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Biochemistry and complete blood count (CBC) results. ND, not determined 
                        
  Horse No. 001 002 003 004 005 006 007 008 009 010 
  Cl (mmol/l) 98.4 94.1 96.2 96.1 97.2 100.4 98.4 100.8 99.0 98.0 
  K (mmol/l) 4.3 4.0 4.1 4.0 4.0 4.3 3.5 3.9 3.9 4.0 
  NA (mmol/l) 135 133 137 136 138 136 141 142 138 139 
  ASAT (U/l) 296 395 692 376 399 552 377 364 357 339 
  CK (U/l) 192 234 903 292 260 279 289 294 198 428 
  GT (U/l) 13 30 27 21 21 25 19 21 20 20 
  Mg (mmol/l) 0.81 0.71 0.87 0.79 0.75 0.80 0.88 0.81 083 0.74 
  SDP (U/l) 0.5 6.4 34.4 13.6 5.7 18.1 8.4 15.5 7.4 3.2 
  ALP (U/l) 283 415 527 376 313 367 306 592 316 549 
  Alb (g/l) 34.1 29.2 35.4 33.2 30.6 33.6 33.5 34.1 36.4 32.1 
  
Bil. Tot 
(µmol/l) 
29.3 23.6 23.8 27.1 20.0 19.3 23.3 29.2 27.9 24.1 
  Glu (mmol/l) 3.9 4.1 5.5 4.5 4.4 4.7 4.2 4.2 4.7 4.6 
  Ca (mmol/l) 3.22 3.13 3.18 3.27 3.13 3.29 3.33 3.36 3.30 3.26 
  Crea (µmol/l) 122 111 97 104 102 97 91 114 113 100 
  Prot (g/l) 60 69 61 70 70 67 73 74 59 68 
                        
  Horse No. 001 002 003 004 005 006 007 008 009 010 
  FB (g/l) 4.4 3.6 3.6 4.3 3.3 4.4 4.0 4.4 3.7 4.6 
  WBC (x109/l) 6.31 7.38 4.20 7.29 4.64 5.01 9.52 7.19 5.92 7.25 
  NEU (x109/l) 4.14 5.06 2.26 4.38 2.47 3.28 5.95 4.45 3.95 4.39 
  LYM (x109/l) 1.69 1.55 1.12 1.74 1.75 1.26 2.94 1.88 1.55 2.08 
  
MONO 
(x109/l) 0.310 0.370 0.209 0.638 0.189 0.278 0.418 0.337 0.224 0.251 
  EOS (x109/l) 0.130 0.358 0.495 0.483 0.204 0.165 0.146 0.498 0.147 0.516 
  BASO (x109/l) 0.040 0.036 0.014 0.053 0.022 0.021 0.059 0.023 0.054 0.015 
  RBC (x1012/l) 8.01 6.63 7.04 7.93 6.67 7.28 7.79 7.30 9.30 6.82 
  HGB (g/l) 132 112 118 131 112 119 130 135 158 116 
  HCT (%) 38.2 30.7 33.6 36.7 33.6 33.2 37.1 38.2 44.2 32.8 
  MCV (fl) 47.7 46.3 47.8 46.2 47.0 45.6 47.6 52.4 47.5 48.1 
  MCH (pg) 16.5 16.8 16.8 16.5 16.8 16.3 16.6 18.5 17.0 17.0 
  MCHC (g/l) 346 363 352 358 359 358 349 352 357 353 
  RDW (%CV) 28.2 25.0 22.9 25.0 26.5 25.0 27.2 24.4 24.4 24.3 
  PLT (x109/l) 137 152 104 149 124 122 160 158 160 145 
  MPV (fl) 10.2 9.35 10.3 ND 6,90 7.03 6.45 10.3 7.14 8.50 
                        
 
